Singapore markets close in 1 hour 42 minutes
  • Straits Times Index

    3,200.37
    +11.87 (+0.37%)
     
  • Nikkei

    28,804.85
    +96.27 (+0.34%)
     
  • Hang Seng

    26,098.46
    +80.93 (+0.31%)
     
  • FTSE 100

    7,198.09
    +7.79 (+0.11%)
     
  • BTC-USD

    62,679.32
    -2,098.91 (-3.24%)
     
  • CMC Crypto 200

    1,491.52
    -43.13 (-2.81%)
     
  • S&P 500

    4,549.78
    +13.59 (+0.30%)
     
  • Dow

    35,603.08
    -6.26 (-0.02%)
     
  • Nasdaq

    15,215.70
    +94.02 (+0.62%)
     
  • Gold

    1,793.50
    +11.60 (+0.65%)
     
  • Crude Oil

    82.36
    -0.14 (-0.17%)
     
  • 10-Yr Bond

    1.6760
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,585.53
    -6.09 (-0.38%)
     
  • Jakarta Composite Index

    6,647.76
    +14.79 (+0.22%)
     
  • PSE Index

    7,289.61
    -22.11 (-0.30%)
     

Pfizer in talks over full license for COVID-19 vaccine in Singapore

  • Oops!
    Something went wrong.
    Please try again later.
Pfizer in talks over full license for COVID-19 vaccine in Singapore
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SINGAPORE, Sept 24 (Reuters) - Pfizer Inc is in discussions with Singapore's Health Sciences Authority regarding obtaining a full license application for its COVID-19 vaccine, the company said in response to a query from Reuters. 

 Pfizer-BioNTech's COVID-19 vaccine has interim authorisation under the pandemic special access route in Singapore. The U.S. Food and Drug Administration granted full approval to the vaccine last month. 

(Reporting by Aradhana Aravindan in Singapore Editing by Ed Davies) 

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting